Literature DB >> 1020751

The clinical course, early prognosis and coronary anatomy of subendocardial infarction.

N P Madigan, B D Rutherford, R L Frye.   

Abstract

The following prospective study was undertaken to observe the clinical course, early prognosis and coronary anatomy of patients with subendocardial infarction. Subendocardial infarction was defined as typical chest apin (greater than 15 minutes), serum enzyme elevation and persistent (greater than 48 hours) new T wave inversion and/or S-T segment depression in the absence of new pathologic Q waves. Fifty consecutive patients were defined, followed in a prospective manner and subjected to early coronary arteriography. A prior history of unstable angina was found in 33 patients (66 per cent); 22 patients (44 per cent) had significant dysrhythmias during the acute hospital phase, and seven patients (14 per cent) had evidence of mild left ventricular failure. Coronary arteriography demonstrated significant lesions (greater than 75 per cent narrowing in at least one vessel) in all 50 patients, with 30 patients (60 per cent) having either double- or triple-vessel disease. Follow-up (mean 10.6 months) revealed that 15 patients (30 per cent) had stable angina, 23 patients (46 per cent) unstable angina and only 12 patients (24 per cent) remained free of angina. Of 28 patients in a medically treated group, acute transmural infarctions developed in six (21 per cent) and one died (3 per cent). We conclude that subendocardial infarction is symptomatically an unstable entity, is associated with severe coronary artery disease and, in a medically treated group, is followed by a significant incidence of early transmural myocardial infarction (21 per cent). Therefore, these patients require in-hospital monitoring, careful follow-up and consideration for early coronary arteriography.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1020751     DOI: 10.1016/0002-9343(76)90497-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Effect of early programmes of high and low intensity exercise on physical performance after transmural acute myocardial infarction.

Authors:  A J Goble; D L Hare; P S Macdonald; R G Oliver; M A Reid; M C Worcester
Journal:  Br Heart J       Date:  1991-03

2.  Seeing the forest through the trees: uncovering phenomic complexity through interactive network visualization.

Authors:  Jeremy L Warner; Joshua C Denny; David A Kreda; Gil Alterovitz
Journal:  J Am Med Inform Assoc       Date:  2014-10-21       Impact factor: 4.497

3.  Non Q wave infarction: exercise test characteristics, coronary anatomy, and prognosis.

Authors:  J P Fox; J M Beattie; M S Salih; M K Davies; W A Littler; R G Murray
Journal:  Br Heart J       Date:  1990-03

4.  After the infarct.

Authors:  C M Oakley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-03

Review 5.  Clinical correlates of the coronary arteriogram.

Authors:  R I Hamby
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

6.  Classification of non-Q-wave myocardial infarction according to electrocardiographic changes.

Authors:  H Ogawa; K Hiramori; K Haze; M Saito; T Sumiyoshi; K Fukami; Y Goto; M Ikeda
Journal:  Br Heart J       Date:  1985-11

7.  Myocardial infarction and the normal arteriogram--possible role of viral myocarditis.

Authors:  D O'Neill; J D McArthur; J A Kennedy; G Clements
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

Review 8.  Indications for coronary angioplasty in acute myocardial ischemic syndromes.

Authors:  P J de Feyter; P W Serruys; P G Hugenholtz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

9.  Residual myocardial jeopardy in patients with Q-wave and non-Q-wave infarctions.

Authors:  J K Bissett; J Matts; B Sharma
Journal:  Br Heart J       Date:  1987-11

10.  Coxsackie B virus infection in coronary care unit patients.

Authors:  D O'Neill; J D McArthur; J A Kennedy; G Clements
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.